Search by Drug Name or NDC
NDC 00025-2762-31 Norpace 150 mg/1 Details
Norpace 150 mg/1
Norpace is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is DISOPYRAMIDE PHOSPHATE.
MedlinePlus Drug Summary
Disopyramide is used to treat certain types of irregular heartbeats). Disopyramide is in a class of medications called antiarrhythmic medications. It works by making your heart more resistant to abnormal activity.
Related Packages: 00025-2762-31Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Disopyramide
Product Information
| NDC | 00025-2762 |
|---|---|
| Product ID | 0025-2762_bad34f2f-efbc-453a-b783-fba7a05ba580 |
| Associated GPIs | 35100010100110 |
| GCN Sequence Number | 000240 |
| GCN Sequence Number Description | disopyramide phosphate CAPSULE 150 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 01131 |
| HICL Sequence Number | 000077 |
| HICL Sequence Number Description | DISOPYRAMIDE PHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | Norpace |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | disopyramide phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, GELATIN COATED |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | DISOPYRAMIDE PHOSPHATE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA017447 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00025-2762-31 (00025276231)
| NDC Package Code | 0025-2762-31 |
|---|---|
| Billing NDC | 00025276231 |
| Package | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2762-31) |
| Marketing Start Date | 1977-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |